MAPK inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

BRAF V600E	Colorectal Cancer	BRAF V600E	Colorectal Cancer	MAPK inhibitor Sensitive: C3 – Early Trials MAPK inhibitor Sensitive : C3	MAPK inhibitor Sensitive: C3 – Early Trials MAPK inhibitor Sensitive : C3
STK11 expression	Prostate Cancer	STK11 expression	Prostate Cancer	SB202190 Sensitive: D – Preclinical SB202190 Sensitive : D	SB202190 Sensitive: D – Preclinical SB202190 Sensitive : D

Associations(2)